Clinical Trials at Northwest Clinical Research Center
As of August 2026, 32 paid clinical trials are recruiting at Northwest Clinical Research Center, located at Northwest Clinical Research Center, 1951 152nd Pl NE #200, Bellevue, WA 98007, phone (425) 453-0404 in Bellevue, Washington. Active studies at this site cover conditions such as Schizophrenia, Major Depressive Disorder and Obesity. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Bellevue
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
33 clinical trials at Northwest Clinical Research Center
·Clear filters·A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
A Study of Brenipatide in Adult Participants With Schizophrenia
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
Common conditions studied in Bellevue
- Schizophrenia (5 active studies)
- Major Depressive Disorder (4 active studies)
- Obesity (4 active studies)
- Alzheimer Disease (3 active studies)
- Depressive Disorder, Major (3 active studies)
- Major Depressive Disorder (MDD) (3 active studies)
Leading research sponsors in Bellevue
- Eli Lilly and Company
- Intra-Cellular Therapies, Inc.
- SWOG Cancer Research Network
- AbbVie
- Amgen
Frequently asked questions
How many paid clinical trials are currently recruiting in Bellevue?
There are approximately 81 recruiting clinical trials in Bellevue, Washington listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Bellevue pay participants?
Most recruiting trials in Bellevue compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Bellevue?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Bellevue?
The most common conditions under active study in Bellevue include Schizophrenia (5), Major Depressive Disorder (4), Obesity (4), Alzheimer Disease (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Bellevue?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Bellevue on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Bellevue?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Bellevue?
Recruiting research sites in Bellevue include Northwest Clinical Research Center, FHCC Overlake, Kaiser Permanente Bellevue Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Bellevue right now?
The largest active categories in Bellevue are Mental health & behavior (15), Cancer & tumors (13), Neurology & pain (13). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Northwest Clinical Research Center?
Northwest Clinical Research Center is located at Northwest Clinical Research Center, 1951 152nd Pl NE #200, Bellevue, WA 98007. Use the Google Maps link in the intro above to get directions.
How do I contact Northwest Clinical Research Center?
You can reach Northwest Clinical Research Center by phone at (425) 453-0404. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.